AQUA BIO TECHNOLOGY ASA: EXERCISE PERIOD OF WARRANTS COMMENCES

by | Jun 28, 2019

Reference is made to the stock exchange notice of Aqua Bio Technology ASA ("ABT"
or the "Company") published on 14 February 2019, regarding independent
subscription rights issued by the Company ("Warrants").

Each Warrant gives the holder a right to subscribe for one (1) share in the
Company at a subscription price of NOK 2.50 per share.  The exercise period for
the Warrants will commence on 30 June 2019.

Holders of Warrants who wish to exercise these may do so by providing written
notice to the Company, on the following address:

                            Aqua Bio Technology ASA
                                Fornebuveien 37
                                  1366 Lysaker
                                     Norway
                          E-mail: arvid@aquabiotech.no

Investors who require issuance of shares through exercise of Warrants shall
receive these as effectively as practically possible after 1 August 2019 (for
investors who have exercised Warrants prior to 31 July 2019) or after 1
September 2019 (for investors who have exercised their Warrants within the end
of 1 September 2019). The Company will provide payment information for share
deposits following exercise of Warrants.

The exercise period for the Warrants expire on 1 September 2019. Warrants that
are not exercised within the end of 1 September 2019 will lapse automatically
without compensation to the holder.

For further information, please contact Arvid Lindberg, Head of sales and
marketing, telephone +47 9824 5410 or arvid@aquabiotech.no

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on the Axess market of the
Oslo Stock Exchange.

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.